ANNA SUMMERFORD: Open Payments
NPI 1144880774 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 90 payments from 15 companies in 2025. Trend: 2023 $1,628 · 2024 $1,345 · 2025 $1,657
Food & beverage: $1,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $580 |
| Madrigal Pharmaceuticals | 8 | $259 |
| Janssen Biotech, Inc. | 10 | $199 |
| Ardelyx, Inc. | 8 | $158 |
| Phathom Pharmaceuticals, Inc. | 15 | $116 |
| GENZYME CORPORATION | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| Novo Nordisk Inc | 2 | $36 |
| Celltrion USA Inc. | 1 | $25 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, SKYRIZI, IBSRELA, DUPIXENT, VOQUEZNA, ENTYVIO.
Industry payments across AL — which companies pay providers there.
